ALK-Abelló A/S (AKBLF) News Today → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free AKBLF Stock Alerts $22.45 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartHeadlinesStock AnalysisAnalyst ForecastsChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 3, 2024 | finanznachrichten.deALK Abello: ALK upgrades its full-year revenue outlookMay 2, 2024 | finance.yahoo.comThree-month interim report (Q1) 2024 (unaudited)May 2, 2024 | markets.businessinsider.comAlk-Abello A-S Bearer and-or registered B is about to announce its earnings — here's what Wall Street expectsMay 2, 2024 | finance.yahoo.comALK upgrades its full-year revenue outlookApril 24, 2024 | finance.yahoo.comInvitation to the presentation of ALK’s first quarter results on Friday 3 May 2024April 18, 2024 | benzinga.comAlaska Air Gr Stock (NYSE:ALK), Quotes and News SummaryMarch 27, 2024 | finance.yahoo.comSave the date for ALK’s Capital Markets Day on 4 June 2024March 14, 2024 | finance.yahoo.comAnnual General Meeting in ALK-Abelló A/S held on 14 March 2024February 16, 2024 | finance.yahoo.comAnnual General Meeting in ALK-Abelló A/S on 14 March 2024February 8, 2024 | finanznachrichten.deALK Abello: Annual report 2023: ALK delivers 9% sales growth with profits up 50%February 8, 2024 | finanznachrichten.deALK Abello: ALK and McMaster researchers discover new cell that remembers allergiesFebruary 8, 2024 | finance.yahoo.comAnnual report 2023: ALK delivers 9% sales growth with profits up 50%February 7, 2024 | finance.yahoo.comALK and McMaster researchers discover new cell that remembers allergiesFebruary 5, 2024 | finance.yahoo.comALK’s 2030 CO2 reduction targets have been approved by SBTiJanuary 31, 2024 | finance.yahoo.comRelease date of annual report 2023 for ALK and webcastJanuary 25, 2024 | finance.yahoo.comALK’s European registration application for house dust mite SLIT-tablet in young children accepted for reviewJanuary 18, 2024 | finance.yahoo.comALK completes first part of phase 1 trial with peanut SLIT-tabletJanuary 4, 2024 | finanznachrichten.deALK Abello: ALK to become sole manufacturer and distributor of skin antigen test for penicillin allergyJanuary 4, 2024 | finance.yahoo.comALK to Become Sole Manufacturer and Distributor of Skin Antigen Test for Penicillin AllergyDecember 21, 2023 | uk.investing.comALK-Abello B (0OIR)December 20, 2023 | finance.yahoo.comALK – Financial calendar for the 2024 financial yearDecember 12, 2023 | finanznachrichten.deALK Abello: ALK expands partnership with Torii in JapanDecember 12, 2023 | finance.yahoo.comALK expands partnership with Torii in JapanNovember 15, 2023 | finance.yahoo.comNine-month interim report (Q3) 2023November 9, 2023 | morningstar.comAlk-Abello A/S Class B ALK BNovember 9, 2023 | finance.yahoo.comRelease date of nine-month interim report (Q3) 2023 for ALK and audio castOctober 16, 2023 | finance.yahoo.comALK-Abelló A/S (ALK-B.CO)October 11, 2023 | msn.comALK-Abello: Promising Strides in Tree Pollen Allergy Vaccine for ChildrenOctober 11, 2023 | finance.yahoo.comLarge Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s tree tablet in childrenAugust 26, 2023 | investing.comALK-Abello B (ALKb)August 24, 2023 | finance.yahoo.comSix-month interim report (Q2) 2023August 18, 2023 | finance.yahoo.comRelease date of six-month interim report (Q2) 2023 for ALK and audio castJune 19, 2023 | finance.yahoo.comPresident & CEO Carsten Hellmann to step down end 2023. Peter Halling appointed as his successorJune 8, 2023 | finance.yahoo.comLarge Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s house dust mite tablet in young childrenMay 9, 2023 | msn.comALK-Abelló A/S reports Q1 resultsMay 9, 2023 | finance.yahoo.comThree-month interim report (Q1) 2023May 1, 2023 | finance.yahoo.comRelease date of three-month interim report (Q1) 2023 for ALK and audio castApril 17, 2023 | finance.yahoo.comALK announces preliminary Q1 figures and confirms its full-year revenue and earnings outlookMarch 31, 2023 | finance.yahoo.comGrant of share-based long-term incentive instruments to members of the Board of Management and key employeesMarch 23, 2023 | finance.yahoo.comAnnual General Meeting in ALK-Abelló A/S held on 23 March 2023March 18, 2023 | nasdaq.comGuru Fundamental Report for ALKFebruary 27, 2023 | finance.yahoo.comAnnual General Meeting in ALK on 23 March 2023February 10, 2023 | finance.yahoo.comALK appoints Claus Steensen Sølje as new Chief Financial Officer (CFO)February 3, 2023 | finanznachrichten.deALK Abello: Annual report 2022: ALK delivers sales growth of 13% with profits up 33% in 2022February 3, 2023 | finance.yahoo.comAnnual report 2022: ALK delivers sales growth of 13% with profits up 33% in 2022February 3, 2023 | finance.yahoo.comRegulatory filing for house dust mite allergy tablet accepted for review in ChinaJanuary 27, 2023 | finance.yahoo.comRelease date of annual report 2022 for ALK and audio castJanuary 25, 2023 | finance.yahoo.comU.S. FDA Approves ALK's ODACTRA® (House Dust Mite Allergen Extract) Tablet for Sublingual Use as Immunotherapy for AdolescentsDecember 21, 2022 | finance.yahoo.comHenriette Mersebach to succeed Henrik Jacobi as Executive Vice President, R&D at ALKDecember 19, 2022 | finance.yahoo.comALK – Financial calendar for the 2023 financial year Get ALK-Abelló A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for AKBLF and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision. Start streaming it now at no cost here AKBLF Media Mentions By Week AKBLF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKBLF News Sentiment▼0.000.55▲Average Medical News Sentiment AKBLF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKBLF Articles This Week▼00▲AKBLF Articles Average Week Get ALK-Abelló A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for AKBLF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News Today DRTSW News Today ARNI News Today ARTLW News Today ASCLF News Today AWKNF News Today AXIM News Today BRRGF News Today BCTXW News Today CLVLY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:AKBLF) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsHow Biden has already won 2024Porter & CompanyUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate CapitalMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALK-Abelló A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
